Floreo announces new research partnership

By Heather | Aug 13, 2020

NationalHumanGenomeResearchInstitute

We are excited to announce we are expanding our scope of lessons.

Our new research partnership with the National Human Genome Research Institute will focus on ADHD Virtual Reality Cognitive Therapy.

We have entered into a collaborative research and development agreement (CRADA) with the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH).

Under the CRADA, Floreo and NHGRI will jointly develop and pilot immersive virtual reality (VR) modules focused on improving cognitive deficits frequently implicated in attention deficit hyperactivity disorder (ADHD).

About the Author

Heather

Heather is Floreo's Director of Customer Success. She makes sure that all of Floreo's customers are comfortable and confident using Floreo. Prior to working at Floreo, Heather worked at Trove (a news start-up) and eBay for Charity. Heather holds an A.B. from Dartmouth College, where she also played varsity basketball (and won an Ivy League Championship) and a M.Ed. from the University of Mary Washington. In her free time she enjoys reading, tennis, skiing, and hiking around Western North Carolina with her husband, two sons, and adorable lab mix, Pepper.

Floreo announces new research partnership

Tags

Heather

Related Posts

Floreo research update

Floreo spotlight: Cuyahoga County Board of Developmental Disabilities

Floreo Announces New Research Partnership to Test Whether Virtual Reality Can Help People on the Autism Spectrum to Develop Critical Social Skills

Building the Research Base for the Use of Floreo VR in ABA Therapy